High fructose intake promotes hepatic steatosis in non-obese children through multiple metabolic and inflammatory pathways, highlighting an underrecognized risk beyond obesity.
A new study, led by Edina Morscher et al., suggests that excessive dietary fructose may contribute to the development of hepatic steatosis, or fatty liver, even in children and adolescents who are not overweight and do not have diabetes.
Researchers performed a narrative review incorporating systematic search elements and evaluated evidence retrieved from major biomedical databases, including PubMed, MEDLINE, EMBASE, Cochrane Library, and Scopus, to assess the hepatic effects of fructose exposure in non-obese pediatric populations. The analysis revealed that fructose exposure triggered a cascade of metabolic disturbances that favored hepatic fat deposition, even in children without obesity or diabetes.
Key mechanistic findings included:
Collectively, these findings suggested that excessive fructose intake may drive fatty liver disease even in metabolically healthy and normal-weight children. The analysis reframed paediatric fatty liver disease as a nutritional rather than purely weight-driven disorder, with hidden fructose exposure emerging as an underrecognized contributor. While important knowledge gaps persisted, stronger prevention strategies and clearer food labelling were positioned as critical tools for protecting liver health in the next generation.
Nutrition and Health
Fructose-induced hepatic steatosis in non-obese children: A comprehensive review
Edina Morscher et al.
Comments (0)